Literature DB >> 19444608

Modulation of glutamate and glycine transporters by niflumic, flufenamic and mefenamic acids.

Suzanne Habjan1, Robert J Vandenberg.   

Abstract

Three fenamates--niflumic, flufenamic and mefenamic acids--were tested for effects on substrate-induced currents of glutamate and glycine transporters (EAAT1, EAAT2, GLYT1b and GLYT2a) expressed in Xenopus laevis oocytes. All fenamates inhibited EAAT1 currents; 100 microM flufenamic acid produced the most inhibition, decreasing the I (max) by 53 +/- 4% (P < 0.001). EAAT2 currents were less sensitive, but 100 microM flufenamic acid inhibited the I (max) by 34 +/- 5% (P = 0.006). All fenamates inhibited GLYT1b currents; 100 microM flufenamic acid produced the most inhibition, decreasing the I (max) by 61 +/- 1% (P < 0.001). At 100 microM, effects on the GLYT2a I (max) were mixed: 13 +/- 2% inhibition by flufenamic acid (P = 0.002), 30 +/- 6% enhancement by niflumic acid (P = 0.002), and no effect by mefenamic acid. Minor effects on substrate affinity suggested non-competitive mechanisms. These data could contribute to the development of selective transport modulators.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444608     DOI: 10.1007/s11064-009-9983-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  44 in total

1.  Zn(2+) inhibits the anion conductance of the glutamate transporter EEAT4.

Authors:  A D Mitrovic; F Plesko; R J Vandenberg
Journal:  J Biol Chem       Date:  2001-05-14       Impact factor: 5.157

2.  Niflumic acid modulates uncoupled substrate-gated conductances in the human glutamate transporter EAAT4.

Authors:  M V Poulsen; R J Vandenberg
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

Review 3.  Toxic effects of nonsteroidal anti-inflammatory drugs in overdose. An overview of recent evidence on clinical effects and dose-response relationships.

Authors:  S C Smolinske; A H Hall; S A Vandenberg; D G Spoerke; P V McBride
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

Review 4.  Anti-inflammatory drugs in the fight against Alzheimer's disease.

Authors:  P L McGeer; E G McGeer
Journal:  Ann N Y Acad Sci       Date:  1996-01-17       Impact factor: 5.691

5.  The structural and electronical factors that contribute affinity for the time-dependent inhibition of PGHS-1 by indomethacin, diclofenac and fenamates.

Authors:  R Pouplana; C Pérez; J Sánchez; J J Lozano; P Puig-Parellada
Journal:  J Comput Aided Mol Des       Date:  1999-05       Impact factor: 3.686

6.  The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.

Authors:  G M Greig; D A Francis; J P Falgueyret; M Ouellet; M D Percival; P Roy; C Bayly; J A Mancini; G P O'Neill
Journal:  Mol Pharmacol       Date:  1997-11       Impact factor: 4.436

7.  Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex.

Authors:  Karen M Cullen; Zoltán Kócsi; Jonathan Stone
Journal:  J Cereb Blood Flow Metab       Date:  2005-12       Impact factor: 6.200

8.  Molecular basis for differential inhibition of glutamate transporter subtypes by zinc ions.

Authors:  R J Vandenberg; A D Mitrovic; G A Johnston
Journal:  Mol Pharmacol       Date:  1998-07       Impact factor: 4.436

9.  Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1.

Authors:  D K Bhattacharyya; M Lecomte; C J Rieke; M Garavito; W L Smith
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

10.  Effects of fenamates and other nonsteroidal anti-inflammatory drugs on rat brain GABAA receptors expressed in Xenopus oocytes.

Authors:  R M Woodward; L Polenzani; R Miledi
Journal:  J Pharmacol Exp Ther       Date:  1994-02       Impact factor: 4.030

View more
  3 in total

1.  Fenamates as TRP channel blockers: mefenamic acid selectively blocks TRPM3.

Authors:  Chihab Klose; Isabelle Straub; Marc Riehle; Felicia Ranta; Dietmar Krautwurst; Susanne Ullrich; Wolfgang Meyerhof; Christian Harteneck
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

2.  Identification of Novel Inhibitors of Auxin-Induced Ca2+ Signaling via a Plant-Based Chemical Screen.

Authors:  Kjell De Vriese; Ellie Himschoot; Kai Dünser; Long Nguyen; Andrzej Drozdzecki; Alex Costa; Moritz K Nowack; Jürgen Kleine-Vehn; Dominique Audenaert; Tom Beeckman; Steffen Vanneste
Journal:  Plant Physiol       Date:  2019-02-08       Impact factor: 8.340

3.  Characterization of the effects of Cl⁻ channel modulators on TMEM16A and bestrophin-1 Ca²⁺ activated Cl⁻ channels.

Authors:  Yani Liu; Huiran Zhang; Dongyang Huang; Jinlong Qi; Jiaxi Xu; Haixia Gao; Xiaona Du; Nikita Gamper; Hailin Zhang
Journal:  Pflugers Arch       Date:  2014-08-01       Impact factor: 3.657

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.